weight loss pill

by University of Bristol edited by Sadie Harley, reviewed by Alexander Pol  Editors’ notes Credit: Unsplash/CC0 Public Domain An innovative new pill could soon offer a new and affordable weight management treatment, following a successful clinical trial involving University of Bristol researchers. The results are published in a paper titled “A randomized, double-blind, placebo-controlled pilot trial with open-label

DISCLOSURES August 25, 2025 GLP-1 receptor agonists are now well established as weight-loss treatments, but until recently, they have been available exclusively as injections. Lilly, headquartered in Indianapolis, announced that the oral GLP-1 receptor agonist orforglipron reduced the average body weight by 12.4% in a phase 3 trial. The effect was comparable to that seen with